Genmab A/S Announces DuoBody Platform Collaboration With Eli Lilly and Company

Published: Jan 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; January 14, 2014 – Genmab A/S (OMX: GEN) announced today a research collaboration with Eli Lilly and Company to use and evaluate Genmab’s DuoBody technology platform for the creation of bispecific antibodies. Under the collaboration, Lilly will initially evaluate the DuoBody technology platform in house.

Help employers find you! Check out all the jobs and post your resume.

Back to news